BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12109909)

  • 1. Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
    Farr CD; Tabet MR; Ball WJ; Fishwild DM; Wang X; Nair AC; Welsh WJ
    J Med Chem; 2002 Jul; 45(15):3257-70. PubMed ID: 12109909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis.
    Paula S; Tabet MR; Keenan SM; Welsh WJ; Ball WJ
    J Mol Biol; 2003 Jan; 325(3):515-30. PubMed ID: 12498800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that distinguish between two related digitalis glycosides, ouabain and digoxin.
    Parhami-Seren B; Bell C; Margolies MN; Haupert GT
    J Immunol; 1999 Oct; 163(8):4360-6. PubMed ID: 10510376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10.
    Schildbach JF; Near RI; Bruccoleri RE; Haber E; Jeffrey PD; Ng SC; Novotny J; Sheriff S; Margolies MN
    J Biol Chem; 1993 Oct; 268(29):21739-47. PubMed ID: 7691815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of peptidic mimics of digoxin from phage-displayed peptide libraries by anti-digoxin antibodies.
    Ball WJ; Wang Z; Malik B; Kasturi R; Dey P; Short MK; Margolies MN
    J Mol Biol; 2000 Aug; 301(1):101-15. PubMed ID: 10926495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional quantitative structure-activity relationship study of the inhibition of Na(+),K(+)-ATPase by cardiotonic steroids using comparative molecular field analysis.
    Farr CD; Burd C; Tabet MR; Wang X; Welsh WJ; Ball WJ
    Biochemistry; 2002 Jan; 41(4):1137-48. PubMed ID: 11802712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.
    Schildbach JF; Shaw SY; Bruccoleri RE; Haber E; Herzenberg LA; Jager GC; Jeffrey PD; Panka DJ; Parks DR; Near RI
    Protein Sci; 1994 May; 3(5):737-49. PubMed ID: 8061604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes.
    Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA
    J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a model cardiac glycoside receptor: comparisons with Na+,K+-ATPase.
    Kasturi R; Yuan J; McLean LR; Margolies MN; Ball WJ
    Biochemistry; 1998 May; 37(19):6658-66. PubMed ID: 9578549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.
    Jeffrey PD; Strong RK; Sieker LC; Chang CY; Campbell RL; Petsko GA; Haber E; Margolies MN; Sheriff S
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10310-4. PubMed ID: 8234291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
    Paula S; Tabet MR; Farr CD; Norman AB; Ball WJ
    J Med Chem; 2004 Jan; 47(1):133-42. PubMed ID: 14695827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying specificity of antidigoxin antibodies using insertional mutagenesis.
    Krykbaev RA; Tsantili P; Jeffrey PD; Margolies MN
    Protein Sci; 2002 Dec; 11(12):2899-908. PubMed ID: 12441388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex.
    Arevalo JH; Stura EA; Taussig MJ; Wilson IA
    J Mol Biol; 1993 May; 231(1):103-18. PubMed ID: 8496956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutations.
    Schildbach JF; Panka DJ; Parks DR; Jager GC; Novotny J; Herzenberg LA; Mudgett-Hunter M; Bruccoleri RE; Haber E; Margolies MN
    J Biol Chem; 1991 Mar; 266(7):4640-7. PubMed ID: 1999439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of antibody affinity by a non-contact residue.
    Schillbach JF; Near RI; Bruccoleri RE; Haber E; Jeffrey PD; Novotny J; Sheriff S; Margolies MN
    Protein Sci; 1993 Feb; 2(2):206-14. PubMed ID: 8443598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro scanning saturation mutagenesis of all the specificity determining residues in an antibody binding site.
    Chen G; Dubrawsky I; Mendez P; Georgiou G; Iverson BL
    Protein Eng; 1999 Apr; 12(4):349-56. PubMed ID: 10325406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display.
    Chukwuocha RU; Hsiao ET; Shaw P; Witztum JL; Chen PP
    J Immunol; 1999 Oct; 163(8):4604-11. PubMed ID: 10510405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.